FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

AstraZeneca Pharmaceuticals Nexium¿ Recall

NEXIUM¿ (esomeprazole magnesium), Delayed-Release capsules, 20 mg, 30-count bottle, Rx…

AstraZeneca Pharmaceuticals LP · Wilmington, DE

Risk level
Class II
Reported by FDA
Jun 24, 2015
Recall ID
D-1141-2015
Check your lot numberHow we source this data

Summary

AstraZeneca Pharmaceuticals recalled Nexium¿ starting Jun 10, 2015. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1141-2015 on Jun 24, 2015. Reason: Presence of Foreign Tablets/Capsules: Confimed customer compliant by a retail pharmacist that an unopened bottle labeled as NEXIUM¿ capsules contained 60 SEROQUEL¿ XR tablets. Status: Terminated.

Why it was recalled

Presence of Foreign Tablets/Capsules: Confimed customer compliant by a retail pharmacist that an unopened bottle labeled as NEXIUM¿ capsules contained 60 SEROQUEL¿ XR tablets.

Product description

NEXIUM¿ (esomeprazole magnesium), Delayed-Release capsules, 20 mg, 30-count bottle, Rx only, Manufactured for AstraZeneca LLC, Wilmington, Distributed by AstraZeneca, AB, Sodertalje, Sweden. NDC 00186-5020-31.

Lot numbers, UPCs & expiration codes

Lot # FC0064; Exp. 05/17

Where it was sold

Nationwide to wholesalers for further distribution at the retail level.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1141-2015
Classification
Class II
Status
Terminated
Recall initiated
Jun 10, 2015
FDA report date
Jun 24, 2015
Quantity
34,524 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
AstraZeneca Pharmaceuticals LP

Original FDA data

Every field from FDA enforcement report D-1141-2015, exactly as published.

Show all FDA fields
City
Wilmington
State
DE
Status
Terminated
Country
United States
Event ID
71483
Address
1800 Concord Pike
Code information
Lot # FC0064; Exp. 05/17
Postal code
19850
Report date
Jun 24, 2015
Product type
Drugs
Recall number
D-1141-2015
Classification
Class II
Recalling firm
AstraZeneca Pharmaceuticals LP
Product quantity
34,524 bottles
Termination date
Sep 27, 2016
Reason for recall
Presence of Foreign Tablets/Capsules: Confimed customer compliant by a retail pharmacist that an unopened bottle labeled as NEXIUM¿ capsules contained 60 SEROQUEL¿ XR tablets.
Voluntary / mandated
Voluntary: Firm initiated
Product description
NEXIUM¿ (esomeprazole magnesium), Delayed-Release capsules, 20 mg, 30-count bottle, Rx only, Manufactured for AstraZeneca LLC, Wilmington, Distributed by AstraZeneca, AB, Sodertalje, Sweden. NDC 00186-5020-31.
Distribution pattern
Nationwide to wholesalers for further distribution at the retail level.
Recall initiation date
Jun 10, 2015
Initial firm notification
Letter
Center classification date
Jun 18, 2015

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1141-2015, published Jun 24, 2015. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls